NORTHERN TRUST CORP - VIVOS THERAPEUTICS INC ownership

VIVOS THERAPEUTICS INC's ticker is VVOS and the CUSIP is 92859E108. A total of 30 filers reported holding VIVOS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.29 and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of VIVOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5,697
-62.3%
29,6550.0%0.00%
Q2 2023$15,124
+49.5%
29,6550.0%0.00%
Q1 2023$10,115
-15.1%
29,6550.0%0.00%
Q4 2022$11,921
-37.3%
29,6550.0%0.00%
Q3 2022$19,000
-63.5%
29,655
-27.3%
0.00%
Q2 2022$52,000
-52.3%
40,7660.0%0.00%
Q1 2022$109,000
+19.8%
40,766
+0.4%
0.00%
Q4 2021$91,000
-45.2%
40,604
-1.0%
0.00%
Q3 2021$166,000
+191.2%
41,027
+257.3%
0.00%
Q2 2021$57,00011,4830.00%
Other shareholders
VIVOS THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
BARD ASSOCIATES INC 201,704$81,0850.04%
PERKINS CAPITAL MANAGEMENT INC 52,000$210.02%
Wealth Alliance Advisory Group, LLC 26,249$10,5520.00%
Apexium Financial, LP 40,667$16,3480.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 3,600$1,4470.00%
GEODE CAPITAL MANAGEMENT, LLC 201,941$810.00%
STATE STREET CORP 91,300$36,7020.00%
TOTH FINANCIAL ADVISORY CORP 200$800.00%
MORGAN STANLEY 1,400$5630.00%
View complete list of VIVOS THERAPEUTICS INC shareholders